Screener
BridgeBio Pharma BBIO Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: BridgeBio Pharma’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001743881-26-000027
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Redeemable convertible noncontrolling interests | (1,018) | (570) |
| Stockholders’ deficit: | ||
| Undesignated preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 500,000,000 shares authorized; 205,867,350 shares issued and 195,284,352 shares outstanding as of June 30, 2026; 202,369,129 shares issued and 194,771,957 shares outstanding as of December 31, 2025 | 206 | 202 |
| Treasury stock, at cost; 10,582,998 shares as of June 30, 2026; 7,597,172 shares as of December 31, 2025 | (533,279) | (323,276) |
| Additional paid-in capital | 2,155,318 | 2,057,646 |
| Accumulated other comprehensive income (loss) | (7) | 12 |
| Accumulated deficit | (4,137,453) | (3,821,194) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's common stock shares issued?
- BridgeBio Pharma (BBIO) reported common stock shares issued of 205.9M in Q2 2026.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about BridgeBio Pharma's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude